mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
8e-06 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-05 |